AroCell
0,504 SEK -1,18 %Vær den første som følger denne virksomhed
AroCell is a biochemistry company. The company conducts research, development, and commercialization of markers for the determination of cell growth and apoptosis. The markers are used in the prognosis, monitoring, and follow-up of cancer patients. The company's products are sold under separate brands. Arocell was founded in 2003 and is headquartered in Uppsala.
Omsætning
36,99 mio.
EBIT %
-160,31 %
P/E
-
Udbytteafkast, %
-
Kursmål
-
Anbefaling
-
Opdateret
-
First North Stockholm
AROC
Daglig lav / høj pris
0,492 / 0,51
SEK
Markedsværdi
116,1 mio. SEK
Aktieomsætning
56,03 t SEK
Volumen
112 t
Seneste videoer
Finanskalender
Delårsrapport
25.10.2023
Årsrapport
22.02.2024
Major OwnersSource: Millistream Market Data AB
| Owner | Capital | Votes |
|---|---|---|
| Labbex Förvaltnings AB | 11,6 % | 11,6 % |
| Avanza Pension | 8,0 % | 8,0 % |
Premium
Not activated
This content is for our Premium customers only.
Viser Alle indholdstyper
